GlaxoSmithKline To Settle 3 Federal Investigations For $3 Billion

LONDON - (Mealey's) GlaxoSmithKline plc (GSK) has reached an agreement in principal to settle three United States federal criminal and civil investigations for $3 billion, the company said Nov. 3 in a press release on its Web site. GSK said the agreement in principle will settle "the Company's...